Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy care continuum communication

	Profile	Recent Articles on Subject
1	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Drugmaker shut down after black schmutz found in injectable weight-loss drug - 13 days ago
2	Jessica Rendall CNET Journalist/Presenter @abcdarwin. Brisbane JournalismBroadcasting	Thousands of Antidepressant Bottles Were Recalled Over 'Impurity' Risk: Here's More Context - 23 days ago FDA Issues Warning Over Some Eye Drop Sales: Here's What to Know - CNET - about 1 year ago
3	Joseph L. Fink III, JD, DSC (Hon.), BSPHARM, FAPhA Pharmacy Times Podcasts creator, books author. Not here often. podcastingwriting	Lawsuit by Deceased Man’s Estate Focuses on Opioid Dispensing - 23 days ago Medication Preparation Error Causes Major Ill Effects for Child - 6 months ago
4	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about drug shortages, what drugmakers didn’t tell Alzheimer’s trial patients and more - 24 days ago STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more - 9 months ago STAT+: Pharmalittle: We are reading about Catalent concerns, a congressional hearing, and more - 9 months ago STAT+: Pharmalittle: We’re reading about GLP-1 drugs’ safety, Novartis nixing a deal, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 11 months ago STAT+: FDA is blasted by advocates for pursuing a deal with data provider that has ties to opioid makers - 11 months ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - 11 months ago STAT+: In response to criticism, FDA publishes new database of wayward clinical trial sponsors - 11 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - 11 months ago STAT+: FDA efforts to oversee foreign drug manufacturing remain inadequate to ensure safety, analysis finds - 12 months ago STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs - about 1 year ago STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India - about 1 year ago STAT+: Pharmalittle: FDA flags safety concerns with CRISPR-based sickle cell treatment; FDA warns about eye drop infection risk - about 1 year ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - about 1 year ago
5	Kathleen Kenny, PharmD, RPh Pharmacy Times Postdoc researcher. Reproductive justice advocate. Toronto, Ontario family wellbeingchild welfarereproductive justiceharm reduction	Communication Skills Are Crucial for Patient Safety - 24 days ago Safe Opioid Prescribing, Storage Are Crucial - 3 months ago
6	MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	What Did the FDA Warn About a Hot Flash Drug? - 2 months ago What Drug Did an FDA Panel Deem Ineffective? - about 1 year ago
7	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 2 months ago
8	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	3 FDA approval dates to watch in the year’s final push - 2 months ago A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 3 months ago After ‘tragic’ bacterial outbreak, lawmakers press FDA to step up foreign inspections - 9 months ago
9	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Nearly 2,000 Pharmaceutical Plants Are Overdue for FDA Checks After COVID Delays - 2 months ago
10	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	FDA sends 2 warning letters after inspecting Chinese syringe manufacturers - 4 months ago FDA finalizes guidance on studying opioid use disorder treatments - 4 months ago FDA sends 3 warning letters in probe of plastic syringes made in China - 8 months ago Baxter sends another safety notice about syringe infusion pump errors - 12 months ago FDA concerned Cardinal Health failed to mitigate risk of incompatible syringes - 12 months ago

Journalists covering drug safety